Cargando…
PB2149: MINIMAL RESIDUAL DISEASE (MRD) DETECTION TRENDING AS A PRIMARY ENDPOINT IN CERBA RESEARCH MULTIPLE MYELOMA (MM) TRIALS
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429039/ http://dx.doi.org/10.1097/01.HS9.0000975356.67572.1c |
| _version_ | 1785090615515545600 |
|---|---|
| author | Gaspo, Rania Claeys, Rowan Sallette, Jerome |
| author_facet | Gaspo, Rania Claeys, Rowan Sallette, Jerome |
| author_sort | Gaspo, Rania |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429039 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104290392023-08-17 PB2149: MINIMAL RESIDUAL DISEASE (MRD) DETECTION TRENDING AS A PRIMARY ENDPOINT IN CERBA RESEARCH MULTIPLE MYELOMA (MM) TRIALS Gaspo, Rania Claeys, Rowan Sallette, Jerome Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429039/ http://dx.doi.org/10.1097/01.HS9.0000975356.67572.1c Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Gaspo, Rania Claeys, Rowan Sallette, Jerome PB2149: MINIMAL RESIDUAL DISEASE (MRD) DETECTION TRENDING AS A PRIMARY ENDPOINT IN CERBA RESEARCH MULTIPLE MYELOMA (MM) TRIALS |
| title | PB2149: MINIMAL RESIDUAL DISEASE (MRD) DETECTION TRENDING AS A PRIMARY ENDPOINT IN CERBA RESEARCH MULTIPLE MYELOMA (MM) TRIALS |
| title_full | PB2149: MINIMAL RESIDUAL DISEASE (MRD) DETECTION TRENDING AS A PRIMARY ENDPOINT IN CERBA RESEARCH MULTIPLE MYELOMA (MM) TRIALS |
| title_fullStr | PB2149: MINIMAL RESIDUAL DISEASE (MRD) DETECTION TRENDING AS A PRIMARY ENDPOINT IN CERBA RESEARCH MULTIPLE MYELOMA (MM) TRIALS |
| title_full_unstemmed | PB2149: MINIMAL RESIDUAL DISEASE (MRD) DETECTION TRENDING AS A PRIMARY ENDPOINT IN CERBA RESEARCH MULTIPLE MYELOMA (MM) TRIALS |
| title_short | PB2149: MINIMAL RESIDUAL DISEASE (MRD) DETECTION TRENDING AS A PRIMARY ENDPOINT IN CERBA RESEARCH MULTIPLE MYELOMA (MM) TRIALS |
| title_sort | pb2149: minimal residual disease (mrd) detection trending as a primary endpoint in cerba research multiple myeloma (mm) trials |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429039/ http://dx.doi.org/10.1097/01.HS9.0000975356.67572.1c |
| work_keys_str_mv | AT gasporania pb2149minimalresidualdiseasemrddetectiontrendingasaprimaryendpointincerbaresearchmultiplemyelomammtrials AT claeysrowan pb2149minimalresidualdiseasemrddetectiontrendingasaprimaryendpointincerbaresearchmultiplemyelomammtrials AT sallettejerome pb2149minimalresidualdiseasemrddetectiontrendingasaprimaryendpointincerbaresearchmultiplemyelomammtrials |